针对瘤微环境,采用基于介质干细胞的输送方法,以有效地输送抗癌药物:一篇更新的综述
Yang Yu1, Ying Tao2, Jingru Ma3
1Department of Emergency and Critical Care, the Second Hospital of Jilin University, Changchun 130000, China.
Biochemical pharmacology
|January 2, 2025
概括
介质细胞干细胞 (MSCs) 提供向的癌症药物输送. 将MSC与纳米粒子结合起来,特别是细胞膜涂层的纳米粒子,显著提高了抗瘤活性和治疗潜力.
科学领域:
- 生物医学工程 生物医学工程
- 在瘤学瘤学.
- 再生医学是一种再生医学.
背景情况:
- 向向癌细胞输送药物仍然是一个重大的治疗挑战.
- 介质细胞干细胞 (MSCs) 具有天然的瘤定位能力,使其成为向输送的理想选择.
- 临床前和临床研究表明,基于MSC的抗癌疗法具有前景.
研究的目的:
- 系统地审查MSCs用于癌症药物输送.
- 探索MSC来源,瘤定位和药物加载/释放机制.
- 讨论先进的策略,包括MSC膜涂层纳米粒子,以提高疗效.
主要方法:
- 临床前和临床研究的文献综述.
- 对MSC瘤微环境相互作用和指导机制的分析.
- 对药物加载,释放动力学和纳米粒子集成的研究.
主要成果:
- 装有抗癌剂的MSC显示出显著的抗瘤活性.
- 与纳米粒子,特别是MSC膜涂层NP的集成增强了治疗潜力.
- 为了优化基于MSC的药物输送系统,存在各种策略.
结论:
- MSCs是针对癌症治疗的有效药物载体.
- 覆盖MSC膜的纳米颗粒是一个尖端的进步.
- 进一步的研究可以优化基于MSC的方法,用于未来的癌症治疗.
更多相关视频
09:18Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds
Published on: July 16, 2018
8.2K
11:37Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting
Published on: June 18, 2018
6.6K
相关概念视频
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
